Click for best price
RadiopharmaceuticalsNuclear Medicine Market Size, Share 2022
The global Radiopharmaceuticals in Nuclear Medicine market was valued at 5060.37 Million USD in 2021 and will grow with a CAGR of 4.93% from 2021 to 2027, based on Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
By Types:
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
By Applications:
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
| Report Attributes |
Report Details |
| Report Title |
2022 Global Radiopharmaceuticals in Nuclear Medicine Industry Status and Prospects Professional Market Research Report Standard Version |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
161 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Radiopharmaceuticals in Nuclear Medicine Market Size Analysis from 2022 to 2027
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Radiopharmaceuticals in Nuclear Medicine Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Radiopharmaceuticals in Nuclear Medicine Industry Impact
Chapter 2 Global Radiopharmaceuticals in Nuclear Medicine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Type
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Type (2016-2021)
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2016-2021)
2.2 Global Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Application
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Application (2016-2021)
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Application (2016-2021)
2.3 Global Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Regions
2.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Regions (2016-2021)
4.2 North America Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.10 South America Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Radiopharmaceuticals in Nuclear Medicine Market Analysis
5.1 North America Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
5.1.1 North America Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.2 North America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
5.3 North America Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
5.4 North America Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
5.4.1 United States Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
5.4.2 Canada Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
5.4.3 Mexico Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 6 East Asia Radiopharmaceuticals in Nuclear Medicine Market Analysis
6.1 East Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
6.1.1 East Asia Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
6.2 East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
6.3 East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
6.4 East Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
6.4.1 China Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
6.4.2 Japan Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
6.4.3 South Korea Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 7 Europe Radiopharmaceuticals in Nuclear Medicine Market Analysis
7.1 Europe Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
7.4 Europe Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
7.4.1 Germany Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.2 UK Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.3 France Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.4 Italy Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.5 Russia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.6 Spain Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.7 Netherlands Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.8 Switzerland Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.9 Poland Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 8 South Asia Radiopharmaceuticals in Nuclear Medicine Market Analysis
8.1 South Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
8.1.1 South Asia Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
8.2 South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
8.3 South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
8.4 South Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
8.4.1 India Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
8.4.2 Pakistan Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Analysis
9.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
9.1.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
9.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
9.3 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
9.4 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
9.4.1 Indonesia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.2 Thailand Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.3 Singapore Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.4 Malaysia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.5 Philippines Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.6 Vietnam Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.7 Myanmar Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 10 Middle East Radiopharmaceuticals in Nuclear Medicine Market Analysis
10.1 Middle East Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
10.1.1 Middle East Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
10.2 Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
10.3 Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
10.4 Middle East Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
10.4.1 Turkey Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.3 Iran Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.5 Israel Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.6 Iraq Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.7 Qatar Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.8 Kuwait Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.9 Oman Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 11 Africa Radiopharmaceuticals in Nuclear Medicine Market Analysis
11.1 Africa Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
11.1.1 Africa Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
11.2 Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
11.3 Africa Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
11.4 Africa Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
11.4.1 Nigeria Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.2 South Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.3 Egypt Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.4 Algeria Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.5 Morocco Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 12 Oceania Radiopharmaceuticals in Nuclear Medicine Market Analysis
12.1 Oceania Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
12.2 Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
12.3 Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
12.4 Oceania Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
12.4.1 Australia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
12.4.2 New Zealand Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 13 South America Radiopharmaceuticals in Nuclear Medicine Market Analysis
13.1 South America Radiopharmaceuticals in Nuclear Medicine Consumption and Value Analysis
13.1.1 South America Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
13.2 South America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
13.3 South America Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
13.4 South America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Major Countries
13.4.1 Brazil Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.2 Argentina Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.3 Columbia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.4 Chile Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.5 Venezuela Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.6 Peru Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.8 Ecuador Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medicine Business
14.1 Bracco Imaging S.P.A.
14.1.1 Bracco Imaging S.P.A. Company Profile
14.1.2 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Cambridge Isotope Laboratories, Inc.
14.2.1 Cambridge Isotope Laboratories, Inc. Company Profile
14.2.2 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Cardinal Health, Inc.
14.3.1 Cardinal Health, Inc. Company Profile
14.3.2 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Covidien, Plc
14.4.1 Covidien, Plc Company Profile
14.4.2 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Specification
14.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Eczacibasi-Monrol
14.5.1 Eczacibasi-Monrol Company Profile
14.5.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Specification
14.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Fujifilm Holdings Corporation
14.6.1 Fujifilm Holdings Corporation Company Profile
14.6.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
14.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 GE Healthcare (Subsidiary Of General Electric Company)
14.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Profile
14.7.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Specification
14.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 IBA Group
14.8.1 IBA Group Company Profile
14.8.2 IBA Group Radiopharmaceuticals in Nuclear Medicine Product Specification
14.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Isotec, Inc. (Sigma-Aldrich)
14.9.1 Isotec, Inc. (Sigma-Aldrich) Company Profile
14.9.2 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Specification
14.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Lantheus Medical Imaging, Inc.
14.10.1 Lantheus Medical Imaging, Inc. Company Profile
14.10.2 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Nordion, Inc.
14.11.1 Nordion, Inc. Company Profile
14.11.2 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Ntp Radioisotopes (Pty), Ltd.
14.12.1 Ntp Radioisotopes (Pty), Ltd. Company Profile
14.12.2 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Siemens Healthcare (Subsidiary Of Siemens AG)
14.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Company Profile
14.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Specification
14.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Taiyo Nippon Sanso Corporation
14.14.1 Taiyo Nippon Sanso Corporation Company Profile
14.14.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
14.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Urenco Limited
14.15.1 Urenco Limited Company Profile
14.15.2 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Specification
14.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Rotem Industries, Ltd., Inc.
14.16.1 Rotem Industries, Ltd., Inc. Company Profile
14.16.2 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Australian Nuclear Association And Technology Organization (ANSTO)
14.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Company Profile
14.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Specification
14.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Board of Radiation And Isotope Technology (BRIT)
14.18.1 Board of Radiation And Isotope Technology (BRIT) Company Profile
14.18.2 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Specification
14.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Institute of Atomic Energy Polatom Radioisotope Centre
14.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Company Profile
14.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Specification
14.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Institute of Isotopes Co., Ltd.
14.20.1 Institute of Isotopes Co., Ltd. Company Profile
14.20.2 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
14.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.21 Institute Of Radioelement (IRE)
14.21.1 Institute Of Radioelement (IRE) Company Profile
14.21.2 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Specification
14.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (2022-2027)
15.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
15.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Type (2022-2027)
15.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2022-2027)
15.3.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2022-2027)
15.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Forecast by Application (2022-2027)
15.5 Radiopharmaceuticals in Nuclear Medicine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
LIST OF TABLES & FIGURES
Figure Product Picture
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure East Asia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure South Korea Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure UK Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure France Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Poland Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure South Asia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Pakistan Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Bangladesh Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Thailand Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Singapore Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Philippines Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Myanmar Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Iran Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure United Arab Emirates Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Israel Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Iraq Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Qatar Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Kuwait Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Oman Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Australia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure New Zealand Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Venezuela Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Peru Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Puerto Rico Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Ecuador Radiopharmaceuticals in Nuclear Medicine Revenue ($) and Growth Rate (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size Analysis from 2022 to 2027 by Consumption Volume
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size Analysis from 2022 to 2027 by Value
Table Global Radiopharmaceuticals in Nuclear Medicine Price Trends Analysis from 2022 to 2027
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Type (2016-2021)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2016-2021)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Application (2016-2021)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Application (2016-2021)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Regions (2016-2021)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Regions (2016-2021)
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Major Manufacturers Capacity and Total Capacity
Table 2016-2021 Major Manufacturers Capacity Market Share
Table 2016-2021 Major Manufacturers Production and Total Production
Table 2016-2021 Major Manufacturers Production Market Share
Table 2016-2021 Major Manufacturers Revenue and Total Revenue
Table 2016-2021 Major Manufacturers Revenue Market Share
Table 2016-2021 Regional Market Capacity and Market Share
Table 2016-2021 Regional Market Production and Market Share
Table 2016-2021 Regional Market Revenue and Market Share
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Regions (2016-2021)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions (2016-2021)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table East Asia Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table South Asia Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Figure North America Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table North America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table North America Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table North America Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Canada Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure East Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure East Asia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table East Asia Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table East Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure China Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure South Korea Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure Germany Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure UK Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure France Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Italy Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Russia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Spain Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Poland Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure South Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure South Asia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table South Asia Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table South Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure India Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Pakistan Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Bangladesh Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Thailand Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Singapore Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Philippines Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Myanmar Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table Middle East Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Iran Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure United Arab Emirates Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Israel Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Iraq Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Qatar Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Kuwait Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Oman Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Africa Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Algeria Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Algeria Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption by Top Countries
Figure Australia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure New Zealand Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure South America Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2016-2021)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (2016-2021)
Table South America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Types
Table South America Radiopharmaceuticals in Nuclear Medicine Consumption Structure by Application
Table South America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Major Countries
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Chile Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Venezuela Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Peru Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Puerto Rico Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Figure Ecuador Radiopharmaceuticals in Nuclear Medicine Consumption Volume from 2016 to 2021
Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Specification
Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Specification
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Specification
Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Specification
GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
IBA Group Radiopharmaceuticals in Nuclear Medicine Product Specification
IBA Group Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Specification
Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Specification
Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Specification
Urenco Limited Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Specification
Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Specification
Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Specification
Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Specification
Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume and Growth Rate Forecast (2022-2027)
Figure Global Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Forecast by Regions (2022-2027)
Table Global Radiopharmaceuticals in Nuclear Medicine Value Forecast by Regions (2022-2027)
Figure North America Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure North America Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure United States Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure East Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure East Asia Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure China Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure South Korea Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure South Korea Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure UK Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure UK Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure France Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure France Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Swizerland Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Swizerland Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Poland Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Poland Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure South Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure South Asia a Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure India Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Pakistan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Pakistan Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Bangladesh Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Bangladesh Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Thailand Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Thailand Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Singapore Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Singapore Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Philippines Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate Forecast (2022-2027)
Figure Philippines Radiopharmaceuticals in Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
Figure Vietnam Radiopharmaceuticals in Nucle
